Clinical factors influencing the decision to transfuse after percutaneous native kidney biopsy

Clinical Kidney Journal
William L WhittierS M Korbet

Abstract

Transfusion of erythrocytes is the most common intervention after a complicated percutaneous renal biopsy (PRB). Anemia is considered to be a leading risk factor for bleeding following a PRB, and based on recent studies of transfusions in hospitalized patients, many institutions are restricting the threshold for erythrocyte transfusion to a lower hemoglobin concentration (Hgb). The purpose of this study is to analyze factors that influence the transfusion decision after a PRB, and to determine whether anemia is truly a risk factor for bleeding or anemic patients are simply more likely to receive a transfusion because of their already lower pre-PRB Hgb. PRB of native kidneys was performed using real-time ultrasound with automated biopsy needles from January 1990 to April 2014. All patients were prospectively followed for bleeding with a 24-h inpatient observation. An intervention for a bleeding complication (BL-I) was defined by undergoing a procedure (cystoscopy, embolization), receiving a blood transfusion (BL-T), death and/or readmission related to the biopsy. To further define the effect of anemia, patients were divided into three pre-PRB Hgb groups: <9.0 g/dL (n = 79), 9.0-11.0 g/dL (n = 266) and >11.0 g/dL (n = 565). BL-I ...Continue Reading

References

Mar 28, 1977·JAMA : the Journal of the American Medical Association·W K BoltonP F Ells
Sep 19, 1977·JAMA : the Journal of the American Medical Association·W K Bolton
Jul 1, 1989·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·B F Murphy, A MacIsaac
Jan 1, 1989·The Journal of Bone and Joint Surgery. American Volume·H R Cowell
Apr 1, 1997·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D M Clive
Jul 13, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·P KhajehdehiB Bastani
May 16, 2002·Seminars in Nephrology·Stephen M Korbet
Sep 24, 2002·JAMA : the Journal of the American Medical Association·Jean Louis VincentUNKNOWN ABC (Anemia and Blood Transfusion in Critical Care) Investigators
Dec 25, 2003·Journal of the American Society of Nephrology : JASN·William L Whittier, Stephen M Korbet
Oct 2, 2004·Kidney International·Carlo MannoFrancesco P Schena
Oct 16, 2004·Current Opinion in Nephrology and Hypertension·William L Whittier, Stephen M Korbet
Apr 15, 2005·Clinical and Experimental Nephrology·Masaaki EiroTsuyoshi Watanabe
Apr 20, 2007·The New England Journal of Medicine·Jacques LacroixUNKNOWN Pediatric Acute Lung Injury and Sepsis Investigators Network
Nov 27, 2007·European Journal of Clinical Investigation·P StrattaG Ciccone
Feb 28, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Bryan WaldoEdmund J Lewis
Jul 28, 2011·The American Journal of Cardiology·Howard A CooperJulio A Panza
Dec 16, 2011·The New England Journal of Medicine·Jeffrey L CarsonUNKNOWN FOCUS Investigators
Apr 28, 2012·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Kristin M CorapiCraig E Gordon
May 15, 2012·Advances in Chronic Kidney Disease·William L Whittier
Jul 4, 2012·Annals of Internal Medicine·Jeffrey L CarsonUNKNOWN Clinical Transfusion Medicine Committee of the AABB
Jul 28, 2012·Clinical Journal of the American Society of Nephrology : CJASN·Camilla TøndelEinar Svarstad
Jan 4, 2013·The New England Journal of Medicine·Càndid VillanuevaCarlos Guarner
Aug 10, 2013·Clinical Journal of the American Society of Nephrology : CJASN·Cynthia B WhitmanBrennan M R Spiegel
Dec 18, 2013·The American Journal of Medicine·Shelley R SalpeterSaurav Chatterjee
Feb 15, 2014·American Journal of Nephrology·Stephen M KorbetWilliam L Whittier
Feb 27, 2014·JAMA : the Journal of the American Medical Association·Matthew W SherwoodSunil V Rao
Aug 20, 2014·Transfusion·Nareg H RoubinianUNKNOWN NHLBI Recipient Epidemiology and Donor Evaluation Study (REDS-III)
Oct 2, 2014·The New England Journal of Medicine·Lars B HolstUNKNOWN Scandinavian Critical Care Trials Group
Oct 2, 2014·The New England Journal of Medicine·Paul C Hébert, Jeffrey L Carson
Mar 12, 2015·The New England Journal of Medicine·Gavin J MurphyUNKNOWN TITRe2 Investigators

❮ Previous
Next ❯

Citations

Sep 7, 2016·Analytical and Bioanalytical Chemistry·Sanduru Thamarai KrishnanSanghyo Kim
Apr 19, 2017·Nephrology·Juan M Mejía-ViletLuis E Morales-Buenrostro
May 10, 2017·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Prakash MuthusamiBairbre Connolly
Oct 6, 2018·Clinical Kidney Journal·Jennifer S LeesBruce Mackinnon
Sep 7, 2019·Nephrology·Rob MacGinleyJeffrey Wong
Oct 6, 2018·Clinical Kidney Journal·William L WhittierStephen Korbet
Feb 20, 2021·Clinical and Experimental Nephrology·Yoshifumi UbaraUNKNOWN Committee of Practical Guide for Kidney Biopsy 2020
Apr 30, 2021·International Urology and Nephrology·Cynthia C LimChieh Suai Tan

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
biopsies
rheology

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.